Eur Urol:3期| 帕唑帕尼用作晚期肾癌患者肾切除术后辅助治疗的疗效

2021-03-01 MedSci原创 MedSci原创

大多数研究表明,VEGFR酪氨酸激酶抑制剂辅助治疗晚期肾癌(RCC)没有任何益处。

大多数研究表明,VEGFR酪氨酸激酶抑制剂辅助治疗晚期肾癌(RCC)没有任何益处

PROTECT(NCT01235962)是一项随机、双盲、安慰剂对照的3期研究,旨在评估帕唑帕尼(pazopanib)用于肾切除术后有高复发风险的局部晚期肾癌患者的疗效。共招募了1538位患者,1:1随机分至帕唑帕尼组和安慰剂组(各 769位患者)。

初步分析结果显示,帕唑帕尼(600 mg)治疗与安慰剂相比在无病生存率方面没有明显差异。本文报告了该研究最终的总存活率(OS)分析。

帕佐帕尼组和安慰剂组分别中位随访了76个月和77个月。帕唑帕尼组和安慰剂组的OS没有显著差异(风险比 1.0,95%CI 0.80-1.26;P>0.9)

与病情较轻的患者相比,T4期患者的OS较差。

体重指数(BMI)≥30 kg/m2的患者与BMI较低的患者相比,OS较好。

与那些在治疗后2年内复发的患者相比,治疗后2年内仍保持病情稳定的患者的OS明显更好。这些发现与该试验的初步结果一致,表明帕佐帕尼辅助治疗对局部晚期肾癌切除术后的患者的OS没有治疗益处。

总之,本研究表明,局部晚期肾癌患者在肾切除术后,接受帕唑帕尼或安慰剂辅助治疗的复发风险均很高,总体存活率相似。因此,不推荐帕唑帕尼用作局部晚期肾癌切除术后的辅助治疗

原始出处:

Motzer Robert J,Russo Paul,Haas Naomi et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol, 2021, 79: 334-338.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1877387, encodeId=133a18e73876b, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Mar 12 13:08:16 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933025, encodeId=95d9193302592, content=<a href='/topic/show?id=001b61108cc' target=_blank style='color:#2F92EE;'>#术后辅助治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61108, encryptionId=001b61108cc, topicName=术后辅助治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d3356, createdName=tongyongming, createdTime=Sun Apr 11 04:08:16 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716288, encodeId=3ad41e16288bd, content=<a href='/topic/show?id=e9f382466b9' target=_blank style='color:#2F92EE;'>#肾切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82466, encryptionId=e9f382466b9, topicName=肾切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770132196036, createdName=gaoxiaoe, createdTime=Sat Nov 20 20:08:16 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945348, encodeId=3a5f9453480d, content=局部晚期是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210304/254cd662a5cf4ddb81353761841aec1d/79ff652d59a34e17aff5a96becd46303.jpg, createdBy=e9ce5401305, createdName=ms2000000322316384, createdTime=Thu Mar 04 08:54:20 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945267, encodeId=db4294526ecd, content=这份研究终于出结果了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Wed Mar 03 22:28:30 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367030, encodeId=ecdc136e030f3, content=<a href='/topic/show?id=8232598e33b' target=_blank style='color:#2F92EE;'>#晚期肾癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59873, encryptionId=8232598e33b, topicName=晚期肾癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e251248, createdName=wujh_7312819, createdTime=Wed Mar 03 11:08:16 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032824, encodeId=afd01032824ce, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Mon Mar 01 23:08:16 CST 2021, time=2021-03-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1877387, encodeId=133a18e73876b, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Mar 12 13:08:16 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933025, encodeId=95d9193302592, content=<a href='/topic/show?id=001b61108cc' target=_blank style='color:#2F92EE;'>#术后辅助治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61108, encryptionId=001b61108cc, topicName=术后辅助治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d3356, createdName=tongyongming, createdTime=Sun Apr 11 04:08:16 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716288, encodeId=3ad41e16288bd, content=<a href='/topic/show?id=e9f382466b9' target=_blank style='color:#2F92EE;'>#肾切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82466, encryptionId=e9f382466b9, topicName=肾切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770132196036, createdName=gaoxiaoe, createdTime=Sat Nov 20 20:08:16 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945348, encodeId=3a5f9453480d, content=局部晚期是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210304/254cd662a5cf4ddb81353761841aec1d/79ff652d59a34e17aff5a96becd46303.jpg, createdBy=e9ce5401305, createdName=ms2000000322316384, createdTime=Thu Mar 04 08:54:20 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945267, encodeId=db4294526ecd, content=这份研究终于出结果了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Wed Mar 03 22:28:30 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367030, encodeId=ecdc136e030f3, content=<a href='/topic/show?id=8232598e33b' target=_blank style='color:#2F92EE;'>#晚期肾癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59873, encryptionId=8232598e33b, topicName=晚期肾癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e251248, createdName=wujh_7312819, createdTime=Wed Mar 03 11:08:16 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032824, encodeId=afd01032824ce, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Mon Mar 01 23:08:16 CST 2021, time=2021-03-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1877387, encodeId=133a18e73876b, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Mar 12 13:08:16 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933025, encodeId=95d9193302592, content=<a href='/topic/show?id=001b61108cc' target=_blank style='color:#2F92EE;'>#术后辅助治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61108, encryptionId=001b61108cc, topicName=术后辅助治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d3356, createdName=tongyongming, createdTime=Sun Apr 11 04:08:16 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716288, encodeId=3ad41e16288bd, content=<a href='/topic/show?id=e9f382466b9' target=_blank style='color:#2F92EE;'>#肾切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82466, encryptionId=e9f382466b9, topicName=肾切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770132196036, createdName=gaoxiaoe, createdTime=Sat Nov 20 20:08:16 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945348, encodeId=3a5f9453480d, content=局部晚期是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210304/254cd662a5cf4ddb81353761841aec1d/79ff652d59a34e17aff5a96becd46303.jpg, createdBy=e9ce5401305, createdName=ms2000000322316384, createdTime=Thu Mar 04 08:54:20 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945267, encodeId=db4294526ecd, content=这份研究终于出结果了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Wed Mar 03 22:28:30 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367030, encodeId=ecdc136e030f3, content=<a href='/topic/show?id=8232598e33b' target=_blank style='color:#2F92EE;'>#晚期肾癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59873, encryptionId=8232598e33b, topicName=晚期肾癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e251248, createdName=wujh_7312819, createdTime=Wed Mar 03 11:08:16 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032824, encodeId=afd01032824ce, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Mon Mar 01 23:08:16 CST 2021, time=2021-03-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1877387, encodeId=133a18e73876b, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Mar 12 13:08:16 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933025, encodeId=95d9193302592, content=<a href='/topic/show?id=001b61108cc' target=_blank style='color:#2F92EE;'>#术后辅助治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61108, encryptionId=001b61108cc, topicName=术后辅助治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d3356, createdName=tongyongming, createdTime=Sun Apr 11 04:08:16 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716288, encodeId=3ad41e16288bd, content=<a href='/topic/show?id=e9f382466b9' target=_blank style='color:#2F92EE;'>#肾切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82466, encryptionId=e9f382466b9, topicName=肾切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770132196036, createdName=gaoxiaoe, createdTime=Sat Nov 20 20:08:16 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945348, encodeId=3a5f9453480d, content=局部晚期是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210304/254cd662a5cf4ddb81353761841aec1d/79ff652d59a34e17aff5a96becd46303.jpg, createdBy=e9ce5401305, createdName=ms2000000322316384, createdTime=Thu Mar 04 08:54:20 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945267, encodeId=db4294526ecd, content=这份研究终于出结果了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Wed Mar 03 22:28:30 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367030, encodeId=ecdc136e030f3, content=<a href='/topic/show?id=8232598e33b' target=_blank style='color:#2F92EE;'>#晚期肾癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59873, encryptionId=8232598e33b, topicName=晚期肾癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e251248, createdName=wujh_7312819, createdTime=Wed Mar 03 11:08:16 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032824, encodeId=afd01032824ce, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Mon Mar 01 23:08:16 CST 2021, time=2021-03-01, status=1, ipAttribution=)]
    2021-03-04 ms2000000322316384

    局部晚期是啥

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1877387, encodeId=133a18e73876b, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Mar 12 13:08:16 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933025, encodeId=95d9193302592, content=<a href='/topic/show?id=001b61108cc' target=_blank style='color:#2F92EE;'>#术后辅助治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61108, encryptionId=001b61108cc, topicName=术后辅助治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d3356, createdName=tongyongming, createdTime=Sun Apr 11 04:08:16 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716288, encodeId=3ad41e16288bd, content=<a href='/topic/show?id=e9f382466b9' target=_blank style='color:#2F92EE;'>#肾切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82466, encryptionId=e9f382466b9, topicName=肾切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770132196036, createdName=gaoxiaoe, createdTime=Sat Nov 20 20:08:16 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945348, encodeId=3a5f9453480d, content=局部晚期是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210304/254cd662a5cf4ddb81353761841aec1d/79ff652d59a34e17aff5a96becd46303.jpg, createdBy=e9ce5401305, createdName=ms2000000322316384, createdTime=Thu Mar 04 08:54:20 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945267, encodeId=db4294526ecd, content=这份研究终于出结果了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Wed Mar 03 22:28:30 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367030, encodeId=ecdc136e030f3, content=<a href='/topic/show?id=8232598e33b' target=_blank style='color:#2F92EE;'>#晚期肾癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59873, encryptionId=8232598e33b, topicName=晚期肾癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e251248, createdName=wujh_7312819, createdTime=Wed Mar 03 11:08:16 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032824, encodeId=afd01032824ce, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Mon Mar 01 23:08:16 CST 2021, time=2021-03-01, status=1, ipAttribution=)]
    2021-03-03 走,走走

    这份研究终于出结果了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1877387, encodeId=133a18e73876b, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Mar 12 13:08:16 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933025, encodeId=95d9193302592, content=<a href='/topic/show?id=001b61108cc' target=_blank style='color:#2F92EE;'>#术后辅助治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61108, encryptionId=001b61108cc, topicName=术后辅助治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d3356, createdName=tongyongming, createdTime=Sun Apr 11 04:08:16 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716288, encodeId=3ad41e16288bd, content=<a href='/topic/show?id=e9f382466b9' target=_blank style='color:#2F92EE;'>#肾切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82466, encryptionId=e9f382466b9, topicName=肾切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770132196036, createdName=gaoxiaoe, createdTime=Sat Nov 20 20:08:16 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945348, encodeId=3a5f9453480d, content=局部晚期是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210304/254cd662a5cf4ddb81353761841aec1d/79ff652d59a34e17aff5a96becd46303.jpg, createdBy=e9ce5401305, createdName=ms2000000322316384, createdTime=Thu Mar 04 08:54:20 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945267, encodeId=db4294526ecd, content=这份研究终于出结果了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Wed Mar 03 22:28:30 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367030, encodeId=ecdc136e030f3, content=<a href='/topic/show?id=8232598e33b' target=_blank style='color:#2F92EE;'>#晚期肾癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59873, encryptionId=8232598e33b, topicName=晚期肾癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e251248, createdName=wujh_7312819, createdTime=Wed Mar 03 11:08:16 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032824, encodeId=afd01032824ce, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Mon Mar 01 23:08:16 CST 2021, time=2021-03-01, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1877387, encodeId=133a18e73876b, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Mar 12 13:08:16 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933025, encodeId=95d9193302592, content=<a href='/topic/show?id=001b61108cc' target=_blank style='color:#2F92EE;'>#术后辅助治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61108, encryptionId=001b61108cc, topicName=术后辅助治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d3356, createdName=tongyongming, createdTime=Sun Apr 11 04:08:16 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716288, encodeId=3ad41e16288bd, content=<a href='/topic/show?id=e9f382466b9' target=_blank style='color:#2F92EE;'>#肾切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82466, encryptionId=e9f382466b9, topicName=肾切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770132196036, createdName=gaoxiaoe, createdTime=Sat Nov 20 20:08:16 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945348, encodeId=3a5f9453480d, content=局部晚期是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210304/254cd662a5cf4ddb81353761841aec1d/79ff652d59a34e17aff5a96becd46303.jpg, createdBy=e9ce5401305, createdName=ms2000000322316384, createdTime=Thu Mar 04 08:54:20 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945267, encodeId=db4294526ecd, content=这份研究终于出结果了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Wed Mar 03 22:28:30 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367030, encodeId=ecdc136e030f3, content=<a href='/topic/show?id=8232598e33b' target=_blank style='color:#2F92EE;'>#晚期肾癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59873, encryptionId=8232598e33b, topicName=晚期肾癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e251248, createdName=wujh_7312819, createdTime=Wed Mar 03 11:08:16 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032824, encodeId=afd01032824ce, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Mon Mar 01 23:08:16 CST 2021, time=2021-03-01, status=1, ipAttribution=)]
    2021-03-01 内科新手

    谢谢梅斯提供这么好的信息,学到很多

    0

相关资讯

新型靶向药物MK-6482在晚期肾癌中显示出显著疗效

在2020年ASCO泌尿生殖系统癌症研讨会上,Dana-Farber癌症研究所的研究人员报告说,靶向缺氧诱导因子(HIF)2-a的口服小分子MK-6482可促进新生血管生长,所有危险类别的肾癌患者的反应率达到24%。

Opdivo/Cabometyx组合疗法用于一线治疗晚期肾癌的III期临床实验成功

"如果获得批准,这种组合可能成为转移性肾细胞癌患者重要的一线治疗新选择。"

PD-L1单抗Bavencio+阿昔替尼:获英国NICE推荐作为晚期肾癌的一线疗法

该药物组合将晚期肾癌患者疾病进展或死亡的风险降低31%,中位无进展生存期提高5.3个月。

Lancet Oncol:派姆单抗联合阿西替尼治疗初治晚期肾癌的疗效优于单用舒尼替尼(Keynote-426)

Keynote-426研究的首次中期分析显示,派姆单抗联合阿西替尼治疗初治晚期肾癌的疗效优于单用舒尼替尼。本文旨在评价派姆单抗联合阿西替尼与舒尼替尼单药相比治疗晚期肾癌患者的长期疗效和安全性。

Nat Med:晚期肾癌免疫治疗应答不佳机制被揭密

肾透明细胞癌(Clear cell renal cell cancer, ccRCC,最常见的肾癌)是泌尿系统常见的恶性肿瘤之一。目前用于治疗晚期肾癌的免疫检查点抑制剂药物如帕博利珠单抗(Keytru

Eur J Cancer:阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好!

在一项随机III期试验中,阿昔替尼(Axitinib)联合派姆单抗(Pembrolizumab)用于晚期肾癌患者显示出了优于舒尼替尼(Sunitinib)的总体存活率(OS)、无进展存活率(PFS)和